Presented this morning at #AACR24 by @huang_lab and Online First in @CR_AACR:
Integration of pan-cancer cell line and single-cell transcriptomic profiles enables inference of therapeutic vulnerabilities in heterogeneous tumors
https://t.co/QWTXfwwFfc
You are invited to the #PGRN 2024 Scientific Meeting
Dates: September 23-25
Location: The Ohio State University, Columbus, OH
In-person meetings will include:
The #PGRN Implementation WG and committees
AllofUs Workshop
More information can be found at https://t.co/bUNWvM43Lk
Tomorrow! ECP Seminar (ECP 8100/PHAR 6160): "Identifying New Therapies for Breast Cancer Patients Via Drug Response Modeling," presented by Robert Gruener, PhD, Post-Doctoral Associate, @huang_lab
I will present my poster which is about sex differences in adult diffuse glioma. This is a collaborative work from the @huang_lab and @be_stranger . If you are interested, please come to PB5083 and check it out! #ASHG23
Excited to share our phase I clinical results for CAN-3110, an oncolytic HSV1, in recurrent glioma. We saw some nice immune recruitment that was associated with survival--especially in patients who had pre-existing HSV1 serology: https://t.co/9xAceJ2X61
Last week, faculty, staff, students—and family—from our department enjoyed our summer outing! A little rain 🌧️ didn’t get us down and we still enjoyed pontoon 🛥️ rides on the lovely St. Croix, chartered by captain @RobertJStraka ! Thanks to all who came out! ☀️
👏 Yuting leads the discovery of the sex differences in intratumoral microbiome and reveals their relationship between host molecular features and drug responses. We are excited about the work and looking forward to do more.
The first selected oral abstract presentation by PhD candidate @yuting_shan on the implications of sex differences in intratumor microbiome on cancer risk and treatment response #PGRN2023
Congratulations to @yuting_shan on her selection to receive the 2023 PGRN presidential abstract award! She will present her abstract at the PGRN 2023 annual meeting in June.
Great summary of our recent PNAS publication from the incredible Weijie Zhang! Proposing treatments for advanced prostate cancer using computational approaches https://t.co/zu2awHpwOW
We’re recruiting!👩🏻🔬👨🏾🔬
📈Hey pharmacometricians!
If you are interested in working with a talented and energetic group of faculty & students, please apply for this tenure track faculty position!
✅ UMN: https://t.co/UptJDlFDl9
External: https://t.co/pubREb10hw
Pls RT! #TwitteRx
#PrecisionMedicines promise to revolutionise patient care. Our new webinar on 7 Feb at 15:00 CET will discuss the unique economic challenges & opportunities for precision medicine and contribute to this ongoing debate. Join here: https://t.co/m0v4w5outM
Our newest work: Sex-differentiated genetic effects on regulation of drug metabolism enzymes and transporters genes, which contribute to phenotypic traits incl disease risk and drug responses. Led by @YingboHuang & in collab with @huang_lab https://t.co/AhBwq6e6tP #SexDifferences
Today at 10:30 am, together with Lesley, we will be moderating the platform session “The past matters for cancer treatment and risk” at #ASHG22. If you are around, please come and check for 4 fantastic talks in this session.
Congratulations to ECP faculty members Scott Chapman, PharmD, and R. Stephanie Huang, PhD, on their well-deserved promotions to professor and professor with tenure, respectively. Thank you for all you do for ECP! @huang_lab#UMNproud